Related Experiment Video
Updated: Feb 15, 2026

Biocytin Recovery and 3D Reconstructions of Filled Hippocampal CA2 Interneurons
Published on: November 20, 2018
T-type Ca2+ Channels: T for Targetable
Marta C Sallán1, Anna Visa1, Soni Shaikh1
1Laboratory of Calcium Signaling, IRBLleida. Universitat de Lleida, Lleida, Spain.
Abstract:
In the past decade, T-type Ca2+ channels (TTCC) have been unveiled as key regulators of cancer cell biology and thus have been proposed as chemotherapeutic targets. Indeed, in vitro and in vivo studies indicate that TTCC pharmacologic blockers have a negative impact on the viability of cancer cells and reduce tumor size, respectively. Consequently mibefradil, a TTCC blocker approved in 1997 as an antihypertensive agent but withdrawn in 1998 because of drug-drug interactions, was granted 10 years later the orphan drug status by the FDA to investigate its efficacy against brain, ovary, and pancreatic cancer. However, the existence of different channel isoforms with distinct physiologic roles, together with the lack of selective pharmacologic agents, has hindered a conclusive chemotherapeutic evaluation. Here, we review the available evidence on TTCC expression, value as prognostic markers, and effectiveness of their pharmacologic blockade on cancer cells in vitro and in preclinical models. We additionally summarize the status of clinical trials using mibefradil against glioblastoma multiforme. Finally, we discuss the future perspectives and the importance of further development of multidisciplinary research efforts on the consideration of TTCCs as biomarkers or targetable molecules in cancer. Cancer Res; 78(3); 603-9. ©2018 AACR.
Insights
T-type Ca2+ channels (TTCC) regulate cancer cell biology and are potential chemotherapeutic targets. Pharmacologic blockers show promise in reducing cancer cell viability and tumor size, warranting further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- T-type Ca2+ channels (TTCC) are increasingly recognized as critical regulators of cancer cell proliferation and survival.
- Pharmacologic blockade of TTCCs has demonstrated anti-cancer effects in preclinical studies.
- Mibefradil, a withdrawn antihypertensive drug, received orphan drug status for investigating its efficacy in brain, ovarian, and pancreatic cancers.
Purpose of the Study:
- To review the evidence on TTCC expression and prognostic value in cancer.
- To evaluate the effectiveness of TTCC pharmacologic blockade in preclinical cancer models.
- To summarize the clinical trial status of mibefradil for glioblastoma multiforme.
Main Methods:
- Literature review of studies on TTCC expression, prognostic value, and pharmacologic blockade in cancer.
- Analysis of in vitro and in vivo preclinical data.
- Summary of ongoing clinical trials involving mibefradil.
Main Results:
- TTCCs play a significant role in cancer cell biology.
- TTCC blockers negatively impact cancer cell viability and tumor growth in preclinical settings.
- Challenges remain due to channel isoform diversity and lack of selective agents.
Conclusions:
- TTCCs represent a promising target for cancer therapy.
- Further research and development of selective TTCC inhibitors are crucial.
- Multidisciplinary efforts are needed to fully realize the potential of TTCCs as biomarkers or therapeutic targets in oncology.
More Related Videos
06:33Author Spotlight: Comprehensive Epigenetic Analysis for Investigating Human Cellular Plasticity and Environmental Adaptation Using Immunofluorescence Assays
Published on: June 28, 2024
07:50Electron Channeling Contrast Imaging for Rapid III-V Heteroepitaxial Characterization
Published on: July 17, 2015
Related Concept Videos
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Types of Hormones
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Channels of Non-Verbal Communication
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...